United Therapeutics (UTHR) Shares Outstanding (2009 - 2026)

United Therapeutics has disclosed Shares Outstanding (Entity) across 18 years of filings, most recently posting $42.7 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) fell 5.61% year-over-year to $42.7 million; the TTM figure through Jun 2026 stood at $42.7 million (down 5.61% YoY), while the FY2025 annual figure was $43.6 million, down 2.65% from the prior year.
• Shares Outstanding (Entity) came in at $42.7 million for Q2 2026 at United Therapeutics, up from $42.2 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $47.0 million in Q4 2023 to a low of $42.2 million in Q1 2026.
• Average Shares Outstanding (Entity) over 5 years is $45.0 million, with a median of $45.1 million recorded in 2025.
• Year-over-year, Shares Outstanding (Entity) increased 3.13% in 2023 and fell 6.47% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $46.0 million in 2022, then gained by 2.19% to $47.0 million in 2023, then slipped by 4.7% to $44.8 million in 2024, then decreased by 2.65% to $43.6 million in 2025, then decreased by 2.21% to $42.7 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $42.7 million in Q2 2026, $42.2 million in Q1 2026, and $43.6 million in Q4 2025.